Neuroendocrine tumors: Clinical practice guidelines in oncology Journal Article
| Authors: | Clark, O. H.; Ajani, J.; Benson, A. B. 3rd; Byrd, D.; Doherty, G. M.; Engstrom, P. F.; Ettinger, D. S.; Gibbs, J. F.; Heslin, M. J.; Kandeel, F.; Kessinger, A.; Kulke, M. H.; Kvols, L.; Nemcek, A. A. Jr; Olson, J. A. Jr; Ratliff, T. W.; Saltz, L.; Schteingart, D. E.; Shah, M. H.; Shibata, S. |
| Article Title: | Neuroendocrine tumors: Clinical practice guidelines in oncology |
| Abstract: | Neuroendocrine tumors are relatively rare. An estimated 25,690 new cases of thyroid cancer will be diagnosed in the United States in 2005, accounting for approximately 1% of all malignancies. Neuroendocrine tumors can be broadly subdivided into tumors that are benign or malignant, functional (i.e., producing a syndrome of hormonal excess) or nonfunctional. The management of neuroendocrine tumors with surgical, medical, or radiation therapies is determined by the specific endocrine glands involved, aggressiveness and stage of the tumor, hormonal concentrations detected, and specific patient needs. These guidelines have been designed to address scenarios presented by 80% of patients and to avoid scenarios relevant to less than 5% of patients. © Journal of the National Comprehensive Cancer Network. |
| Keywords: | excision; clinical trial; review; splenectomy; doxorubicin; interferon; antineoplastic agent; pancreaticoduodenectomy; paraganglioma; dacarbazine; nccn clinical practice guidelines; cyclophosphamide; vincristine; practice guideline; oncology; neuroendocrine tumor; postoperative complication; liver metastasis; lung small cell cancer; proton pump inhibitor; pancreas tumor; carcinoma; hyperparathyroidism; recurrent disease; merkel cell tumor; carcinoid; thyroid carcinoma; octreotide; cholecystectomy; pheochromocytoma; beta adrenergic receptor blocking agent; endocrine disease; adrenal tumor; omeprazole; neuroendocrine tumors; streptozocin; insulinoma; pancreas islet cell tumor; cryotherapy; triple vaccine; histamine h2 receptor antagonist; hypophysis tumor; phenoxybenzamine; lansoprazole; gastrinoma; glucagonoma; somatostatinoma; vipoma; adrenalectomy; sipple syndrome; multiple endocrine neoplasia; islet cell cancer; men-1; men-2; diazoxide; dopamine receptor stimulating agent; metirosine; serum albumin i 131 |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 4 |
| Issue: | 2 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2006-02-01 |
| Start Page: | 102 |
| End Page: | 138 |
| Language: | English |
| PROVIDER: | scopus |
| DOI: | 10.6004/jnccn.2006.0013 |
| PUBMED: | 16451769 |
| DOI/URL: | |
| Notes: | - "Export Date: 4 June 2012" - "Source: Scopus" |
